Figure 3 shows the distribution of serum IL-6, TNF-α, and IL-1β levels in clinical subsets such as mucocutaneous, musculoskeletal, renal, serous, CNS, and hematological subsets among SLE patients. This evidence concerns the gene IL6 and systemic lupus erythematosus.